Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Lysozyme (Muramidase).
Lysozyme is a glycoside hydrolase that selectively catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in bacterial peptidoglycan, serving as a critical antimicrobial agent in innate immunity.
5950
89.09 g/mol
-3
(2S)-2-aminopropanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Lysozyme (Muramidase) across standard consumer modalities.
Lysozyme requires low-shear blending and strict moisture control to prevent mechanical denaturation and hygroscopic clumping within the capsule shell.
The high-heat environment of standard pectin deposition causes irreversible unfolding of the lysozyme protein, necessitating specialized low-temperature formulation strategies.
The substantial molecular weight and dosage requirements of lysozyme compromise the tensile strength of thin-film polymers, leading to poor dissolution profiles and limited payload.
Ready to launch a product featuring Lysozyme (Muramidase)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Lysozyme (Muramidase) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Lysozyme (Muramidase) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation